Financials Healthconn Corp.

Equities

6665

TW0006665003

Advanced Medical Equipment & Technology

End-of-day quote Taipei Exchange 06:00:00 2024-04-25 pm EDT 5-day change 1st Jan Change
27.35 TWD +3.80% Intraday chart for Healthconn Corp. +5.19% -4.04%

Valuation

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Capitalization 1 10,370 4,406 6,807 2,304 2,167 1,585
Enterprise Value (EV) 1 9,855 3,807 6,296 1,759 1,770 1,102
P/E ratio 46 x 16.7 x 24.2 x 19.8 x 58 x 62.4 x
Yield 1.23% 3.42% 3% 4.39% 1.47% 1.3%
Capitalization / Revenue 9.37 x 2.55 x 3.46 x 1.53 x 1.59 x 1.03 x
EV / Revenue 8.9 x 2.2 x 3.2 x 1.17 x 1.3 x 0.71 x
EV / EBITDA 28 x 9.39 x 14.9 x 9.71 x 22.3 x 13.7 x
EV / FCF 194 x 22.1 x 25.5 x 6.19 x 54.4 x 12.2 x
FCF Yield 0.52% 4.52% 3.92% 16.1% 1.84% 8.18%
Price to Book 12.6 x 4.52 x 6.13 x 2.33 x 2.35 x 1.68 x
Nbr of stocks (in thousands) 45,252 45,253 45,378 44,909 45,061 45,350
Reference price 2 229.2 97.37 150.0 51.30 48.10 34.95
Announcement Date 4/27/18 4/29/19 4/27/20 4/23/21 4/19/22 4/25/23
1TWD in Million2TWD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net sales 1 1,107 1,729 1,965 1,507 1,363 1,545
EBITDA 1 351.7 405.6 421.8 181.2 79.25 80.44
EBIT 1 305.5 348.8 378.5 149.3 52.35 60.86
Operating Margin 27.59% 20.17% 19.27% 9.91% 3.84% 3.94%
Earnings before Tax (EBT) 1 307.7 354.4 371.4 157.7 67.17 70.28
Net income 1 229.4 271 286.2 118 37.43 25.44
Net margin 20.72% 15.67% 14.57% 7.83% 2.75% 1.65%
EPS 2 4.985 5.833 6.200 2.590 0.8300 0.5600
Free Cash Flow 1 50.92 172.2 246.5 284.1 32.53 90.11
FCF margin 4.6% 9.96% 12.55% 18.85% 2.39% 5.83%
FCF Conversion (EBITDA) 14.48% 42.47% 58.45% 156.77% 41.05% 112.02%
FCF Conversion (Net income) 22.2% 63.55% 86.14% 240.69% 86.9% 354.19%
Dividend per Share 2 2.827 3.333 4.500 2.250 0.7061 0.4560
Announcement Date 4/27/18 4/29/19 4/27/20 4/23/21 4/19/22 4/25/23
1TWD in Million2TWD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net Debt 1 - - - - - -
Net Cash position 1 515 599 511 544 397 483
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 50.9 172 247 284 32.5 90.1
ROE (net income / shareholders' equity) 32.5% 30.1% 27.4% 11.2% 3.91% 2.73%
ROA (Net income/ Total Assets) 18.8% 16.6% 14.6% 5.16% 1.84% 2.21%
Assets 1 1,222 1,636 1,960 2,286 2,032 1,150
Book Value Per Share 2 18.20 21.60 24.50 22.00 20.50 20.80
Cash Flow per Share 2 11.30 12.20 11.70 19.70 18.60 16.90
Capex 1 29.6 17 23.1 6.18 26 69.2
Capex / Sales 2.67% 0.98% 1.18% 0.41% 1.9% 4.48%
Announcement Date 4/27/18 4/29/19 4/27/20 4/23/21 4/19/22 4/25/23
1TWD in Million2TWD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. 6665 Stock
  4. Financials Healthconn Corp.